Dancing with numbers: measuring experiences with among multiply marginalized groups
Abstract
The aim of this study was to analyze the Explicit Discrimination Scale (EDS), in order to determine its capacity to reflect intersectional experiences with discrimination among groups subjected to class, race, and gender oppression. The study was based on data from a study conducted in a representative sample of students (n = 1,023) at Federal University of Santa Catarina, Brazil, regularly enrolled during the first semester of 2012. The statistical analysis included estimation of the relative frequencies of each of the 18 items in the EDS, as well as the main reasons, stratified by sex/gender, color/race, and socioeconomic status. Negative binomial regression models allowed assessing whether sex/gender, race/color, and socioeconomic status are predictors of the discrimination score, even after adjusting for covariates that potentially affect the target associations. The results of the analysis of each of the instrument's 18 items suggest that the EDS allows measurement of discrimination in among multiply marginalized groups, since it draws out the experiences with discrimination in minority subgroups, such as low-income black women. Still, this tendency was not observed in the instrument's global score, suggesting that it does not allow positioning the respondent along a spectrum of discrimination that includes less and more intense expressions of the phenomenon. Future studies are needed to deal with this observed limitation and which thus lend greater visibility to the…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.